Fatty Acid Synthase Inhibitor Platensimycin Intervenes the Development of Nonalcoholic Fatty Liver Disease in a Mouse Model
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease affecting about 25% of world population, while there are still no approved targeted therapies. Although platensimycin (PTM) was first discovered to be a broad-spectrum antibiotic, it was also effective against type II diabetes in a...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2021-12-01
|
| Seria: | Biomedicines |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.mdpi.com/2227-9059/10/1/5 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|